Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Plans $0.09 Monthly Dividend

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) announced a monthly dividend on Wednesday, December 31st. Investors of record on Thursday, January 15th will be paid a dividend of 0.0905 per share by the investment management company on Friday, January 30th. This represents a c) annualized dividend and a yield of 14.6%. The ex-dividend date is Thursday, January 15th.

Neuberger Berman High Yield Strategies Fund Stock Performance

Shares of Neuberger Berman High Yield Strategies Fund stock opened at $7.44 on Friday. The business has a 50-day moving average of $7.30 and a two-hundred day moving average of $7.41. Neuberger Berman High Yield Strategies Fund has a 1 year low of $6.62 and a 1 year high of $7.94.

Institutional Trading of Neuberger Berman High Yield Strategies Fund

Several hedge funds have recently bought and sold shares of the stock. Mercer Global Advisors Inc. ADV acquired a new position in shares of Neuberger Berman High Yield Strategies Fund in the third quarter valued at approximately $80,000. CoreCap Advisors LLC bought a new stake in Neuberger Berman High Yield Strategies Fund in the 3rd quarter valued at $94,000. XTX Topco Ltd bought a new stake in Neuberger Berman High Yield Strategies Fund in the 2nd quarter valued at $113,000. MRA Advisory Group boosted its stake in Neuberger Berman High Yield Strategies Fund by 10.9% in the 3rd quarter. MRA Advisory Group now owns 17,261 shares of the investment management company’s stock worth $129,000 after purchasing an additional 1,693 shares during the period. Finally, Apollon Wealth Management LLC increased its holdings in Neuberger Berman High Yield Strategies Fund by 100.1% during the 2nd quarter. Apollon Wealth Management LLC now owns 29,082 shares of the investment management company’s stock worth $220,000 after purchasing an additional 14,547 shares in the last quarter.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.